Article Information
History
- April 22, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yifei Xu1,2,#,*,
- Kuiama Lewandowski3,*,
- Louise O Downs4,5,
- James Kavanagh1,2,
- Thomas Hender3,
- Sheila Lumley4,5,
- Katie Jeffery4,
- Dona Foster1,2,
- Nicholas D Sanderson1,2,
- Ali Vaughan1,2,
- Marcus Morgan4,
- Richard Vipond3,
- Miles Carroll3,
- Timothy Peto1,2,4,
- Derrick Crook1,2,4,
- A Sarah Walker1,2,
- Philippa C Matthews2,4,5,* and
- Steven T Pullan3,*
- 1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
- 2NIHR Oxford Biomedical Research Centre, University of Oxford, United Kingdom
- 3Public Health England, National Infection Service, Porton Down, Salisbury, United Kingdom
- 4Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom
- 5Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom
- ↵#Corresponding author:
Yifei Xu, Corresponding author email:
yifei.xu{at}ndm.ox.ac.uk
↵* YX and KL contributed equally, PCM and STP contributed equally.
Posted April 22, 2020.
Nanopore metagenomic sequencing of influenza virus directly from respiratory samples: diagnosis, drug resistance and nosocomial transmission
